Close

RBC Capital Remains Bullish on AcelRx Pharma (ACRX) Following Positive SAP302 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


Go back to RBC Capital Remains Bullish on AcelRx Pharma (ACRX) Following Positive SAP302 Trial
ACELRX PHARMA (NASDAQ: ACRX) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $5.88 
Open $0.86    52 Week Low $2.40 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $-1.50 
Volume 610